Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

Authors:

Abstract
Background. Alemtuzumab is an emerging therapy for refractory lymphoproliferative disorders. The associated long-term risks of infection remain poorl

This publication has 23 references indexed in Scilit: